Dr. Jun Sun is a tenured Professor of Medicine at the University of Illinois at Chicago (UIC), U.S.A.. She is an elected fellow of American Gastroenterological Association (AGA) and American Physiological Society (APS). She chairs the AGA microbiome section. Her research interests are host-microbiome interactions in inflammation and cancer. Her key achievements include 1) characterization of vitamin D receptor regulation of intestinal barrier and microbiome in inflammation and cancer, 2) identification of dysbiosis and intestinal dysfunction in amyotrophic lateral sclerosis (ALS), 3) characterization of bacteria in regulating intestinal stem cells and leading to cancer, and 4) identification and characterization of the Salmonella protein AvrA in host-bacterial interactions
Ravi Shridhar, MD, is a board-certified radiation oncologist who is an authority on advanced TheraSphere radioembolization treatment and specializes in treating patients with gastrointestinal, genitourinary and lung cancers. A former Chief of Radiation Oncology at the Moffitt Cancer Center in Tampa, he is known for his excellence in brachytherapy, chemoradiotherapy, combined modality therapy, stereotactic radiosurgery, conformal radiotherapy, image-guided radiotherapy and more. Patients diagnosed with adenocarcinomas, bone cancer, anal neoplasms, esophageal cancer, colorectal cancer, pancreatic and prostate cancer, cholangiocarcinoma and metastatic cancers are regularly referred to his care due to his proven clinical excellence.
André-Jean Remy is Head of the Hepatology and Gastroenterology Unit and the Social Medicine Unit at Perpignan Hospital, France. He is a specialist in viral hepatitis in drug users, prisoners, and other at-risk populations and, as part of his role, he is in charge of a prison medical unit, retention medical center, and primary care access unit. Dr. Remy is also Medical Coordinator of a Mobile Hepatitis Team which works with at-risk populations to provide point-of-care testing, mobile FibroScan® liver stiffness testing, advanced on-site consultations, social screening and diagnosis, access to treatment, educational workshops, and staff training. Head of Hepatology and Gastroenterology Unit & of Social Medicine Unit of Perpignan Hospital, one of 41 french viral hepatitis expert unit Social medicine include jailhouse medical unit, retention center medical and primary care access unit Medical coordinator of Mobil Hepatitis Team, a new concept of HCV/HBV patients care: 1. Screening by Dried Blood Spot (DBS) HIV HBV HCV 2. Mobile Fibroscan* in different sites 3. Social screening and diagnosis (EPICES score) 4. Outreach center with specific health care workers 5 days/7 5. Free blood tests in primary care if no social insurance 6. Advanced on-site specialist consultation 7. Access to obligatory pre-treatment commissions. 8. Individual psycho-educative sessions 9. Collective educative workshops 10. Staff training 11. Drug users prevention 12. Peer to peer program 13.Low-cost specific patients mobile phones 14.Specific one-day hospitalizations before and after antiviral treatment 15. Green thread: outside DBS and FIBROSCAN* in a specific converted truck. Member of French hepatitis B and C guidelines follow-up national staff President of ANGH (french national association of none university gastroenterologists) Administrator of AFEF (french liver diseases association) Clinical research about viral hepatitis in drug users and inmates since 1999 the University of Reims and University of Montpellier Specialist of viral hepatitis in drug users, inmates and precarious populations More than 180 scientific articles; 60 articles or communications in congress in 2012 to 2018
BÉLA HUNYADY, MD, Ph.D., Doctor of Hungarian Academy of Sciences. Specialties: internal medicine, gastroenterology, clinical pharmacology. Full professor at the University of Pécs, Hungary, head of Department of Gastroenterology, at Somogy County Kaposi Mór Teaching Hospital, Kaposvár, Hungary. His clinical and scientific activities include liver cirrhosis, viral hepatitis, other chronic liver diseases, inflammatory bowel diseases, acid-related disorders, therapeutic endoscopy procedures. The previous president of the Hungarian Society of Gastroenterology, past and elected president of the Hepatology Section of the Hungarian Society of Gastroenterology, member of the Advisory Committee of Hungarian Board of Gastroenterology, co-chair of the Hungarian National Hepatitis Committee.
I currently hold an Academy of Finland Research Fellowship, which is comparable to a tenure track position, at the Faculty of Sport and Health Sciences, University of Jyväskylä, Finland. I am also a Docent (Adjunct Professor) in Bacteriology at the Faculty of Medicine, University of Turku, Finland. My research team focuses on studying host-gut microtia interactions related to health and disease. Our approach has been in detecting microbiota-related phenomena in human cohorts and then proving the biological significance and the underlying mechanisms of the phenomena using cellular and animal models. In this way, we have found ways to treat metabolic diseases, such as non-alcoholic fatty liver disease, by using or targeting specific microbes.